Leonardo da Vinci may have had an eye condition that gave him an unusual ability to recreate three-dimensional shapes in his sculptures and paintings, according to new research
Professor Christopher Tyler, of City, University of London, has discovered that the great Italian artist had a vision disorder known as strabismus. With this condition, a person's eyes appear to be pointing in different directions, with only one eye being used to process the visual scene at any one time.
Professor Tyler made his discovery by measuring eyes in six masterpieces thought to be portraits or self-portraits of da Vinci, including his works Vitruvian Man and Salvator Mundi, the most expensive painting of all time.
These measurements suggest that da Vinci had an intermittent version of the condition, which allowed him to switch between using two eyes (stereoscopic vision) to give him the depth of perception, and using just one eye (monocular vision) when he wanted to interpret a three- dimensional image on a flat, two-dimensional canvas.
Professor Tyler said: "Several great artists, from Rembrandt to Picasso, are thought to have had strabismus, and it seems that da Vinci had it too. "The weight of converging evidence suggests that it has Vinci had intermittent exotropia – where an eye turns outwards – with a resultant ability to switch to monocular vision, using just one eye.
"The condition is rather convenient for a painter since viewing the world with one eye allows direct comparison with the flat image being drawn or painted. Having strangled would perhaps explain da Vinci's great facility for depicting the three-dimensional solidity of faces and objects in the world and the distant depth of recession of mountainous scenes."
Professor Tyler fitted circles and ellipses to the pupils, irises, and eyelid openings on the artwork and then measured the relative positions of these features. I found that there was evidence of strabismus in all six pieces of work. The study, Evidence That Leonardo da Vinci Had Strabismus, has been published in the journal JAMA Ophthalmology.